Chicago Capital LLC Purchases 1,775 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Chicago Capital LLC lifted its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 8.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 23,358 shares of the biotechnology company’s stock after purchasing an additional 1,775 shares during the period. Chicago Capital LLC’s holdings in Axon Enterprise were worth $13,882,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Geode Capital Management LLC grew its holdings in shares of Axon Enterprise by 2.0% in the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after purchasing an additional 35,320 shares during the last quarter. Westfield Capital Management Co. LP grew its holdings in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC grew its holdings in shares of Axon Enterprise by 13.9% in the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after purchasing an additional 83,265 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Axon Enterprise by 1.6% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after purchasing an additional 9,090 shares during the last quarter. Finally, Groupama Asset Managment bought a new position in shares of Axon Enterprise in the third quarter worth approximately $200,000. Institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the transaction, the insider now directly owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. This trade represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock valued at $30,721,337 in the last quarter. 5.70% of the stock is owned by insiders.

Axon Enterprise Price Performance

AXON opened at $652.18 on Monday. The stock has a 50-day moving average price of $619.63 and a 200-day moving average price of $483.68. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a market cap of $49.73 billion, a PE ratio of 168.52, a P/E/G ratio of 6.54 and a beta of 1.05. Axon Enterprise, Inc. has a 1 year low of $247.04 and a 1 year high of $698.67.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on AXON. Robert W. Baird lifted their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. TD Cowen began coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. Needham & Company LLC lifted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Finally, Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $524.85.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.